In re Donohue’s Empirical Analysis
632 F.2d 123 · 1980
Citation profile
7 federal appellate · 2 district ·
How this case has been cited
Cited by 18 later decisions — most recently December 2017
7 federal appellate · 2 district ·
Later decisions citing this case, by decade. The current decade is in progress, and our corpus holds fewer opinions from the most recent years, so the latest bars are undercounted — not a real decline.
Relationships
Applies 35 U.S.C. § 102 · 35 U.S.C. § 103
Relies on In re Petering · In re LeGrice · Swain v. Mallory · In re Kiekhaefer · Application of Eric D. Brown
Most-quoted passages
The sentences later courts lift from this opinion, ranked by how many decisions quote each — the parts of the opinion doing the work. These counts are smaller than the citation total above because most of the 18 citing decisions cite the case generally; a passage count includes only decisions quoting that exact language verbatim.
“proof of utility is not a prerequisite to availability of a prior art reference under 35 U.S.C. § 102(b)”
2 later decisions quote this exact passage“Donohue I "). 2 There is no need to discuss the details of that opinion; however, a summary of the pertinent facts is appropriate for a full understanding of the issues before us. 3 The present invention relates to 2,2',6,6'-tetramethylbiphenyl-4,4'-dicarboxylic acid compounds which are suitable for producing polymers used to form shaped objects, such as film, fibers, or molded parts. Claim 1, which is the sole independent claim on appeal, is illustrative: 4 2,2',6,6'-tetramethylbiphenyl-4,4'-dicarboxylic acid compound comprising said acid, an acyl halide derivative thereof, or a simple ester thereof. 5 The PTO has rejected all the appealed claims under 35 U.S.C. Sec. 102(b) "as anticipated by Nomura [et al.], optionally in view of Lincoln and Walker [et al.].”
1 later decision quote this exact passagee.g. In Re John a Donohue
How this case has been treated — in progress
Whether each later court followed, distinguished, criticized, or overruled this decision. The treatment classification (task #35) runs highest-cited cases first and lights up here as it reaches this one.